Analysts predict that CRH Medical Corporation (NASDAQ:CRHM) will announce sales of $29.50 million for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for CRH Medical’s earnings. The lowest sales estimate is $28.40 million and the highest is $30.60 million. CRH Medical posted sales of $27.33 million in the same quarter last year, which suggests a positive year over year growth rate of 7.9%. The company is scheduled to report its next earnings report on Wednesday, August 7th.
On average, analysts expect that CRH Medical will report full year sales of $129.10 million for the current financial year, with estimates ranging from $125.70 million to $132.30 million. For the next fiscal year, analysts forecast that the business will post sales of $144.18 million, with estimates ranging from $132.40 million to $159.90 million. Zacks Investment Research’s sales calculations are an average based on a survey of research analysts that that provide coverage for CRH Medical.
CRH Medical (NASDAQ:CRHM) last announced its quarterly earnings data on Wednesday, March 13th. The company reported $0.02 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.02. The firm had revenue of $32.02 million for the quarter, compared to analyst estimates of $31.40 million.
Separately, Clarus Securities restated a “buy” rating on shares of CRH Medical in a research report on Wednesday, March 20th.
CRH Medical stock opened at $2.95 on Thursday. CRH Medical has a one year low of $2.51 and a one year high of $4.50.
CRH Medical Company Profile
CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.
Read More: How to interpret a stock’s beta number
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.